Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Treatment with a Novel Small Molecule Dual Factor IIa/Xa Inhibitor Protects Against Coagulopathy and Organ Dysfunction in a Baboon Model of Staphylococcus Aureus Sepsis

Robert Silasi, Ravi Shankar Keshari, Tomohiro Abe, Girija Regmi, Cristina Lupu, Joe Simmons, Nils Pfaff, Stefan Heitmeier, Florea Lupu

Blood (2024) 144 (Supplement 1): 3988.

https://doi.org/10.1182/blood-2024-203669

Published: 2024

Journal Articles

Synthetic Pentasaccharide Fondaparinux (Arixtra ® ) Reduces Sepsis Induced Coagulopathy and Promotes Survival in the Baboon Model of E. coli Sepsis

Ravi Shankar Keshari, PhD, Robert Silasi, PhD, Narcis Ioan Popescu, PhD, Cristina Lupu, PhD, Charles Esmon, PhD, Florea Lupu, PhD

Blood (2017) 130 (Supplement 1): 2375.

https://doi.org/10.1182/blood.V130.Suppl_1.2375.2375

Published: 2017

Journal Articles

Bacteremia, Not Coagulation Proteases Contribute to In Vivo Complement Activation in Sepsis

Ravi Shankar Keshari, PhD, Robert Silasi-Mansat, PhD, Cristina Lupu, PhD, Fletcher B. Taylor, Jr., MD, Florea Lupu, PhD

Blood (2016) 128 (22): 275.

https://doi.org/10.1182/blood.V128.22.275.275

Published: 2016

Journal Articles

Role of Androgen Dependent TFPI-Regulating Protein (ADTRP) in Vascular Development and Function

Maulin Mukeshchandra Patel, Robert Silasi-Mansat, PhD, Ravi Shankar Keshari, PhD, Christopher L. Sansam, PhD, David A. Jones, PhD, Cristina Lupu, PhD, Florea Lupu, PhD

Blood (2016) 128 (22): 556.

https://doi.org/10.1182/blood.V128.22.556.556

Published: 2016

Journal Articles

Complement C5 Inhibition Blocks the Cytokine Storm and Consumptive Coagulopathy By Decreasing Lipopolysaccharide (LPS) Release in E. coli Sepsis

Ravi Shankar Keshari, PhD, Robert Silasi-Mansat, PhD, Narcis I. Popescu, PhD, Marybeth Langer, PhD, Hala Chaaban, MD, Cristina Lupu, PhD, Mark K. Coggeshall, Steven DeMarco, PhD, Florea Lupu, PhD

Blood (2015) 126 (23): 765.

https://doi.org/10.1182/blood.V126.23.765.765

Published: 2015

NARROW

Treatment with a Novel Small Molecule Dual Factor IIa/Xa Inhibitor Protects Against Coagulopathy and Organ Dysfunction in a Baboon Model of Staphylococcus Aureus Sepsis

Synthetic Pentasaccharide Fondaparinux (Arixtra ® ) Reduces Sepsis Induced Coagulopathy and Promotes Survival in the Baboon Model of E. coli Sepsis

Bacteremia, Not Coagulation Proteases Contribute to In Vivo Complement Activation in Sepsis

Role of Androgen Dependent TFPI-Regulating Protein (ADTRP) in Vascular Development and Function

Complement C5 Inhibition Blocks the Cytokine Storm and Consumptive Coagulopathy By Decreasing Lipopolysaccharide (LPS) Release in E. coli Sepsis

Email alerts

ASH Publications

American Society of Hematology

Treatment with a Novel Small Molecule Dual Factor IIa/Xa Inhibitor Protects Against Coagulopathy and Organ Dysfunction in a Baboon Model of Staphylococcus Aureus Sepsis

Synthetic Pentasaccharide Fondaparinux (Arixtra ® ) Reduces Sepsis Induced Coagulopathy and Promotes Survival in the Baboon Model of E. coli Sepsis

Bacteremia, Not Coagulation Proteases Contribute to In Vivo Complement Activation in Sepsis

Role of Androgen Dependent TFPI-Regulating Protein (ADTRP) in Vascular Development and Function

Complement C5 Inhibition Blocks the Cytokine Storm and Consumptive Coagulopathy By Decreasing Lipopolysaccharide (LPS) Release in E. coli Sepsis

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only